// App-Quantinova.ai

14605 2014 BOS : Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor

Researchers

Presenter

  • Nabil G Seidah

Principal Investigators

  • Marlys L Koschinsky

Medical Centers

  • University of Windsor, Windsor, ON, Canada

  • Clin Res Inst of Montreal, Montreal, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Coronary Artery Disease

  • Hypercholesterolemia, Familial, 1

  • Liver cancer

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved